Industry: Medical Devices & Consumables
Published Date: 2025-11-02
Pages: 111 Pages
Report ld: 5351222
Request Sample
Customized Report
Insulin Injection Equipment Market Size(US$)

CAGR 2025-2031
11.2%
Market Size,2031
USD 43,780
Million
Market Snapshot
Source: Secondary research, interviews with experts, and QYResearch analysis
The global Insulin Injection Equipment market size was US$ 21030 million in 2024 and is forecast to a readjusted size of US$ 43780 million by 2031 with a CAGR of 11.2% during the forecast period 2025-2031.
By 2025, the evolving U.S. tariff policy is poised to inject considerable uncertainty into the global economic landscape. This report delves into the latest U.S. tariff measures and the corresponding policy responses across the globe, evaluating their impacts on Insulin Injection Equipment market competitiveness, regional economic performance, and supply chain configurations.
Insulin injection equipment refers to the medical devices and supplies used by individuals with diabetes to administer insulin into their bodies. Insulin is a hormone that regulates blood sugar levels, and people with diabetes, particularly those with type 1 diabetes and some with type 2 diabetes, require regular insulin injections to manage their condition. Insulin injection equipment includes various components designed to safely and effectively deliver insulin as prescribed by a healthcare professional.
Smart insulin pens are equipped with Bluetooth connectivity and companion smartphone apps. They allow users to track insulin doses, monitor blood glucose levels, and receive reminders for injections. These pens can provide valuable insights into insulin management.
The global Insulin Injection Equipment market is strategically segmented by company, region (country), by Type, and by Application. This report empowers stakeholders to capitalize on emerging opportunities, optimize product strategies, and outperform competitors through data-driven insights on sales, revenue, and forecasts across regions, by Type, and by Application for 2020-2031.
MARKET SEGMENTATION
CHAPTER OUTLINE
Chapter 1: Report scope, executive summary, and market evolution scenarios (short/mid/long term).
Chapter 2: Quantitative analysis of Insulin Injection Equipment market size and growth potential at global, regional, and country levels.
Chapter 3: Competitive benchmarking of manufacturers (revenue, market share, M&A, R&D focus).
Chapter 4: Type-based segmentation analysis – Uncovering blue ocean markets (e.g., Insulin Needle in China).
Chapter 5: Application-based segmentation analysis – High-growth downstream opportunities (e.g., Clinic in India).
Chapter 6: Regional sales and revenue breakdown by company, type, application and customer.
Chapter 7: Key manufacturer profiles – Financials, product portfolios, and strategic developments.
Chapter 8: Market dynamics – Drivers, restraints, regulatory impacts, and risk mitigation strategies.
Chapter 9: Actionable conclusions and strategic recommendations.
WHY THIS REPORT
Beyond standard market data, this analysis provides a clear profitability roadmap, empowering you to:
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Insulin Injection Equipment value chain, addressing:
- Market entry risks/opportunities by region
- Product mix optimization based on local practices
- Competitor tactics in fragmented vs. consolidated markets
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
We identify regional market threats and growth prospects to guide your overseas layout.
We adjust product portfolios in line with local consumption habits.
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Market Overview
1.1 Insulin Injection Equipment Product Scope
1.2 Insulin Injection Equipment by Type
1.2.1 Global Insulin Injection Equipment Sales by Type (2020 & 2024 & 2031)
1.2.2 Insulin Pen
1.2.3 Insulin Needle
1.2.4 Insulin Syringe
1.2.5 Others
1.3 Insulin Injection Equipment by Application
1.3.1 Global Insulin Injection Equipment Sales Comparison by Application (2020 & 2024 & 2031)
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Others
1.4 Global Insulin Injection Equipment Market Estimates and Forecasts (2020-2031)
1.4.1 Global Insulin Injection Equipment Market Size in Value Growth Rate (2020-2031)
1.4.2 Global Insulin Injection Equipment Market Size in Volume Growth Rate (2020-2031)
1.4.3 Global Insulin Injection Equipment Price Trends (2020-2031)
1.5 Assumptions and Limitations
2 Market Size and Prospective by Region
2.1 Global Insulin Injection Equipment Market Size by Region: 2020 VS 2024 VS 2031
2.2 Global Insulin Injection Equipment Retrospective Market Scenario by Region (2020-2025)
2.2.1 Global Insulin Injection Equipment Sales Market Share by Region (2020-2025)
2.2.2 Global Insulin Injection Equipment Revenue Market Share by Region (2020-2025)
2.3 Global Insulin Injection Equipment Market Estimates and Forecasts by Region (2026-2031)
2.3.1 Global Insulin Injection Equipment Sales Estimates and Forecasts by Region (2026-2031)
2.3.2 Global Insulin Injection Equipment Revenue Forecast by Region (2026-2031)
2.4 Major Region and Emerging Market Analysis
2.4.1 North America Insulin Injection Equipment Market Size and Prospective (2020-2031)
2.4.2 Europe Insulin Injection Equipment Market Size and Prospective (2020-2031)
2.4.3 China Insulin Injection Equipment Market Size and Prospective (2020-2031)
2.4.4 Japan Insulin Injection Equipment Market Size and Prospective (2020-2031)
3 Global Market Size by Type
3.1 Global Insulin Injection Equipment Historic Market Review by Type (2020-2025)
3.1.1 Global Insulin Injection Equipment Sales by Type (2020-2025)
3.1.2 Global Insulin Injection Equipment Revenue by Type (2020-2025)
3.1.3 Global Insulin Injection Equipment Price by Type (2020-2025)
3.2 Global Insulin Injection Equipment Market Estimates and Forecasts by Type (2026-2031)
3.2.1 Global Insulin Injection Equipment Sales Forecast by Type (2026-2031)
3.2.2 Global Insulin Injection Equipment Revenue Forecast by Type (2026-2031)
3.2.3 Global Insulin Injection Equipment Price Forecast by Type (2026-2031)
3.3 Different Types Insulin Injection Equipment Representative Players
4 Global Market Size by Application
4.1 Global Insulin Injection Equipment Historic Market Review by Application (2020-2025)
4.1.1 Global Insulin Injection Equipment Sales by Application (2020-2025)
4.1.2 Global Insulin Injection Equipment Revenue by Application (2020-2025)
4.1.3 Global Insulin Injection Equipment Price by Application (2020-2025)
4.2 Global Insulin Injection Equipment Market Estimates and Forecasts by Application (2026-2031)
4.2.1 Global Insulin Injection Equipment Sales Forecast by Application (2026-2031)
4.2.2 Global Insulin Injection Equipment Revenue Forecast by Application (2026-2031)
4.2.3 Global Insulin Injection Equipment Price Forecast by Application (2026-2031)
4.3 New Sources of Growth in Insulin Injection Equipment Application
5 Competition Landscape by Players
5.1 Global Insulin Injection Equipment Sales by Players (2020-2025)
5.2 Global Top Insulin Injection Equipment Players by Revenue (2020-2025)
5.3 Global Insulin Injection Equipment Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Insulin Injection Equipment as of 2024)
5.4 Global Insulin Injection Equipment Average Price by Company (2020-2025)
5.5 Global Key Manufacturers of Insulin Injection Equipment, Manufacturing Sites & Headquarters
5.6 Global Key Manufacturers of Insulin Injection Equipment, Product Type & Application
5.7 Global Key Manufacturers of Insulin Injection Equipment, Date of Enter into This Industry
5.8 Manufacturers Mergers & Acquisitions, Expansion Plans
6 Region Analysis
6.1 North America Market: Players, Segments, Downstream and Major Customers
6.1.1 North America Insulin Injection Equipment Sales by Company
6.1.1.1 North America Insulin Injection Equipment Sales by Company (2020-2025)
6.1.1.2 North America Insulin Injection Equipment Revenue by Company (2020-2025)
6.1.2 North America Insulin Injection Equipment Sales Breakdown by Type (2020-2025)
6.1.3 North America Insulin Injection Equipment Sales Breakdown by Application (2020-2025)
6.1.4 North America Insulin Injection Equipment Major Customer
6.1.5 North America Market Trend and Opportunities
6.2 Europe Market: Players, Segments, Downstream and Major Customers
6.2.1 Europe Insulin Injection Equipment Sales by Company
6.2.1.1 Europe Insulin Injection Equipment Sales by Company (2020-2025)
6.2.1.2 Europe Insulin Injection Equipment Revenue by Company (2020-2025)
6.2.2 Europe Insulin Injection Equipment Sales Breakdown by Type (2020-2025)
6.2.3 Europe Insulin Injection Equipment Sales Breakdown by Application (2020-2025)
6.2.4 Europe Insulin Injection Equipment Major Customer
6.2.5 Europe Market Trend and Opportunities
6.3 China Market: Players, Segments, Downstream and Major Customers
6.3.1 China Insulin Injection Equipment Sales by Company
6.3.1.1 China Insulin Injection Equipment Sales by Company (2020-2025)
6.3.1.2 China Insulin Injection Equipment Revenue by Company (2020-2025)
6.3.2 China Insulin Injection Equipment Sales Breakdown by Type (2020-2025)
6.3.3 China Insulin Injection Equipment Sales Breakdown by Application (2020-2025)
6.3.4 China Insulin Injection Equipment Major Customer
6.3.5 China Market Trend and Opportunities
6.4 Japan Market: Players, Segments, Downstream and Major Customers
6.4.1 Japan Insulin Injection Equipment Sales by Company
6.4.1.1 Japan Insulin Injection Equipment Sales by Company (2020-2025)
6.4.1.2 Japan Insulin Injection Equipment Revenue by Company (2020-2025)
6.4.2 Japan Insulin Injection Equipment Sales Breakdown by Type (2020-2025)
6.4.3 Japan Insulin Injection Equipment Sales Breakdown by Application (2020-2025)
6.4.4 Japan Insulin Injection Equipment Major Customer
6.4.5 Japan Market Trend and Opportunities
7 Company Profiles and Key Figures
7.1 Becton
7.1.1 Becton Company Information
7.1.2 Becton Business Overview
7.1.3 Becton Insulin Injection Equipment Sales, Revenue and Gross Margin (2020-2025)
7.1.4 Becton Insulin Injection Equipment Products Offered
7.1.5 Becton Recent Development
7.2 Dickinson and Company (BD)
7.2.1 Dickinson and Company (BD) Company Information
7.2.2 Dickinson and Company (BD) Business Overview
7.2.3 Dickinson and Company (BD) Insulin Injection Equipment Sales, Revenue and Gross Margin (2020-2025)
7.2.4 Dickinson and Company (BD) Insulin Injection Equipment Products Offered
7.2.5 Dickinson and Company (BD) Recent Development
7.3 Eli Lilly
7.3.1 Eli Lilly Company Information
7.3.2 Eli Lilly Business Overview
7.3.3 Eli Lilly Insulin Injection Equipment Sales, Revenue and Gross Margin (2020-2025)
7.3.4 Eli Lilly Insulin Injection Equipment Products Offered
7.3.5 Eli Lilly Recent Development
7.4 Novo Nordisk
7.4.1 Novo Nordisk Company Information
7.4.2 Novo Nordisk Business Overview
7.4.3 Novo Nordisk Insulin Injection Equipment Sales, Revenue and Gross Margin (2020-2025)
7.4.4 Novo Nordisk Insulin Injection Equipment Products Offered
7.4.5 Novo Nordisk Recent Development
7.5 Roche
7.5.1 Roche Company Information
7.5.2 Roche Business Overview
7.5.3 Roche Insulin Injection Equipment Sales, Revenue and Gross Margin (2020-2025)
7.5.4 Roche Insulin Injection Equipment Products Offered
7.5.5 Roche Recent Development
7.6 Insulet Corporation
7.6.1 Insulet Corporation Company Information
7.6.2 Insulet Corporation Business Overview
7.6.3 Insulet Corporation Insulin Injection Equipment Sales, Revenue and Gross Margin (2020-2025)
7.6.4 Insulet Corporation Insulin Injection Equipment Products Offered
7.6.5 Insulet Corporation Recent Development
7.7 Medtronic
7.7.1 Medtronic Company Information
7.7.2 Medtronic Business Overview
7.7.3 Medtronic Insulin Injection Equipment Sales, Revenue and Gross Margin (2020-2025)
7.7.4 Medtronic Insulin Injection Equipment Products Offered
7.7.5 Medtronic Recent Development
7.8 Tandem Diabetes Care
7.8.1 Tandem Diabetes Care Company Information
7.8.2 Tandem Diabetes Care Business Overview
7.8.3 Tandem Diabetes Care Insulin Injection Equipment Sales, Revenue and Gross Margin (2020-2025)
7.8.4 Tandem Diabetes Care Insulin Injection Equipment Products Offered
7.8.5 Tandem Diabetes Care Recent Development
7.9 Ypsomed
7.9.1 Ypsomed Company Information
7.9.2 Ypsomed Business Overview
7.9.3 Ypsomed Insulin Injection Equipment Sales, Revenue and Gross Margin (2020-2025)
7.9.4 Ypsomed Insulin Injection Equipment Products Offered
7.9.5 Ypsomed Recent Development
7.10 Valeritas
7.10.1 Valeritas Company Information
7.10.2 Valeritas Business Overview
7.10.3 Valeritas Insulin Injection Equipment Sales, Revenue and Gross Margin (2020-2025)
7.10.4 Valeritas Insulin Injection Equipment Products Offered
7.10.5 Valeritas Recent Development
7.11 Sanofi
7.11.1 Sanofi Company Information
7.11.2 Sanofi Business Overview
7.11.3 Sanofi Insulin Injection Equipment Sales, Revenue and Gross Margin (2020-2025)
7.11.4 Sanofi Insulin Injection Equipment Products Offered
7.11.5 Sanofi Recent Development
7.12 Animas
7.12.1 Animas Company Information
7.12.2 Animas Business Overview
7.12.3 Animas Insulin Injection Equipment Sales, Revenue and Gross Margin (2020-2025)
7.12.4 Animas Insulin Injection Equipment Products Offered
7.12.5 Animas Recent Development
7.13 Beta Bionics
7.13.1 Beta Bionics Company Information
7.13.2 Beta Bionics Business Overview
7.13.3 Beta Bionics Insulin Injection Equipment Sales, Revenue and Gross Margin (2020-2025)
7.13.4 Beta Bionics Insulin Injection Equipment Products Offered
7.13.5 Beta Bionics Recent Development
7.14 Cellnovo
7.14.1 Cellnovo Company Information
7.14.2 Cellnovo Business Overview
7.14.3 Cellnovo Insulin Injection Equipment Sales, Revenue and Gross Margin (2020-2025)
7.14.4 Cellnovo Insulin Injection Equipment Products Offered
7.14.5 Cellnovo Recent Development
7.15 Copernicus
7.15.1 Copernicus Company Information
7.15.2 Copernicus Business Overview
7.15.3 Copernicus Insulin Injection Equipment Sales, Revenue and Gross Margin (2020-2025)
7.15.4 Copernicus Insulin Injection Equipment Products Offered
7.15.5 Copernicus Recent Development
7.16 Dance Biopharm
7.16.1 Dance Biopharm Company Information
7.16.2 Dance Biopharm Business Overview
7.16.3 Dance Biopharm Insulin Injection Equipment Sales, Revenue and Gross Margin (2020-2025)
7.16.4 Dance Biopharm Insulin Injection Equipment Products Offered
7.16.5 Dance Biopharm Recent Development
7.17 Insulet
7.17.1 Insulet Company Information
7.17.2 Insulet Business Overview
7.17.3 Insulet Insulin Injection Equipment Sales, Revenue and Gross Margin (2020-2025)
7.17.4 Insulet Insulin Injection Equipment Products Offered
7.17.5 Insulet Recent Development
7.18 MannKind
7.18.1 MannKind Company Information
7.18.2 MannKind Business Overview
7.18.3 MannKind Insulin Injection Equipment Sales, Revenue and Gross Margin (2020-2025)
7.18.4 MannKind Insulin Injection Equipment Products Offered
7.18.5 MannKind Recent Development
7.19 Owen Mumford
7.19.1 Owen Mumford Company Information
7.19.2 Owen Mumford Business Overview
7.19.3 Owen Mumford Insulin Injection Equipment Sales, Revenue and Gross Margin (2020-2025)
7.19.4 Owen Mumford Insulin Injection Equipment Products Offered
7.19.5 Owen Mumford Recent Development
7.20 SOOIL
7.20.1 SOOIL Company Information
7.20.2 SOOIL Business Overview
7.20.3 SOOIL Insulin Injection Equipment Sales, Revenue and Gross Margin (2020-2025)
7.20.4 SOOIL Insulin Injection Equipment Products Offered
7.20.5 SOOIL Recent Development
7.21 West Pharma
7.21.1 West Pharma Company Information
7.21.2 West Pharma Business Overview
7.21.3 West Pharma Insulin Injection Equipment Sales, Revenue and Gross Margin (2020-2025)
7.21.4 West Pharma Insulin Injection Equipment Products Offered
7.21.5 West Pharma Recent Development
8 Insulin Injection Equipment Manufacturing Cost Analysis
8.1 Insulin Injection Equipment Key Raw Materials Analysis
8.1.1 Key Raw Materials
8.1.2 Key Suppliers of Raw Materials
8.2 Proportion of Manufacturing Cost Structure
8.3 Manufacturing Process Analysis of Insulin Injection Equipment
8.4 Insulin Injection Equipment Industrial Chain Analysis
9 Marketing Channel, Distributors and Customers
9.1 Marketing Channel
9.2 Insulin Injection Equipment Distributors List
9.3 Insulin Injection Equipment Customers
10 Insulin Injection Equipment Market Dynamics
10.1 Insulin Injection Equipment Industry Trends
10.2 Insulin Injection Equipment Market Drivers
10.3 Insulin Injection Equipment Market Challenges
10.4 Insulin Injection Equipment Market Restraints
11 Research Findings and Conclusion
12 Appendix
12.1 Research Methodology
12.1.1 Methodology/Research Approach
12.1.1.1 Research Programs/Design
12.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
12.1.2 Data Source
12.1.2.1 Secondary Sources
12.1.2.2 Primary Sources
12.2 Author Details
12.3 Disclaimer
TABLE OF FIGURES
List of Tables
List of Figures
KEY QUESTIONS ADDRESSED BY THE REPORT
Related Reports
The global market for Insulin Injection Equipment was estimated to be worth US$ 23150 million in 2025 and is projected to reach US$ 48190 million, growing at a CAGR of 11.2% from 2026 to 2032.
Published Date: 2026-06-16
Pages: 156
USD 3950.00
(Single User License)
The global Insulin Injection Equipment market was valued at US$ 23150 million in 2025 and is anticipated to reach US$ 48190 million by 2032, at a CAGR of 11.2% from 2026 to 2032.
Published Date: 2026-04-17
Pages: 146
USD 2900.00
(Single User License)
The global Insulin Injection Equipment market is projected to grow from US$ 21030 million in 2024 to US$ 43780 million by 2031, at a CAGR of 11.2% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2025-11-02
Pages: 190
USD 4900.00
(Single User License)
The global market for Insulin Injection Equipment was estimated to be worth US$ 21030 million in 2024 and is forecast to a readjusted size of US$ 43780 million by 2031 with a CAGR of 11.2% during the forecast period 2025-2031.
Published Date: 2025-01-13
Pages: 164
USD 3950.00
(Single User License)
The global market for Insulin Injection Equipment was valued at US$ 21030 million in the year 2024 and is projected to reach a revised size of US$ 43780 million by 2031, growing at a CAGR of 11.2% during the forecast period.
Published Date: 2025-01-13
Pages: 116
USD 2900.00
(Single User License)
The global market for Insulin Injection Equipment was estimated to be worth US$ 23150 million in 2025 and is projected to reach US$ 48190 million, growing at a CAGR of 11.2% from 2026 to 2032.
Published: 2026-06-16
Pages: 156
The global Insulin Injection Equipment market was valued at US$ 23150 million in 2025 and is anticipated to reach US$ 48190 million by 2032, at a CAGR of 11.2% from 2026 to 2032.
Published: 2026-04-17
Pages: 146
The global Insulin Injection Equipment market is projected to grow from US$ 21030 million in 2024 to US$ 43780 million by 2031, at a CAGR of 11.2% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2025-11-02
Pages: 190
The global market for Insulin Injection Equipment was estimated to be worth US$ 21030 million in 2024 and is forecast to a readjusted size of US$ 43780 million by 2031 with a CAGR of 11.2% during the forecast period 2025-2031.
Published: 2025-01-13
Pages: 164
The global market for Insulin Injection Equipment was valued at US$ 21030 million in the year 2024 and is projected to reach a revised size of US$ 43780 million by 2031, growing at a CAGR of 11.2% during the forecast period.
Published: 2025-01-13
Pages: 116
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
WHY THIS REPORT
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now